Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2017) 51 P029 | DOI: 10.1530/endoabs.51.P029

1Paediatric Endocrinology Unit, Cork University Hospital, Cork, Ireland; 2Paediatric Nephrology Unit, Our Lady’s Children Hospital, Crumlin, Dublin, Ireland.


Introduction: Hypercalcaemia in Williams-Beuren syndrome (WBS) is usually mild and transient, but may be severe in about 5% of new presentations. Often some children will not respond well to traditional therapies.

Case report: We describe three cases of acute hypercalcaemia and their management in a regional Paediatric unit. Case 1: A 16-month-old known WBS girl, presented with irritability, reduced feeding. Corrected serum calcium was 4.51 mmol/l. She was managed acutely with intravenous fluids and frusemide. Serial blood chemistry showed a downward trend of the serum total and ionised calcium. Oral prednisolone was started at 1 mg/kg per day, and gradually tapered over 4 months. Case 2: A 9-month-old girl admitted for investigation of failure to thrive. Corrected serum calcium was 3.78 mmol/l. She was acutely managed with intravenous fluids and furosemide. 1 mg/kg per day oral prednisolone initiated and tapered over 2 months. She presented twice in the following 10 months with symptomatic hypercalcaemia (>4 mmol/l). She received 1 dose of intravenous pamidronate (1 mg/kg) during one presentation and this was effective and safe. Case 3: A 13-month-old girl presented with failure to thrive, withcorrected serum calcium 3.99 mmol/l. She received the traditional therapies initially, which were ineffective. Intravenous pamidronate at 1 mg/kg was given due to recalcitrant hypercalcaemia. Furosemide and prednisolone were discontinued following sustained normocalcaemia. Cases 2 and 3 were diagnosed WBS following their presentations. All cases demonstrated bilateral medullary nephrocalcinosis. They were managed on a low calcium diet.

Conclusion: Treatment of hypercalcaemia in WBS is achieved traditionally with intravenous fluids, loop diuretics, steroids, and a low calcium diet. In this case series, 2/3 cases required bisphosphonate therapy to effectively restore normocalcaemia. Bisphosphonates are now used more commonly in Paediatric Endocrinology and are found to be safe and effective in this case series.

Keywords: Williams-Beuren syndrome, bisphosphonate, hypercalcaemia

Volume 51

45th Meeting of the British Society for Paediatric Endocrinology and Diabetes

British Society for Paediatric Endocrinology and Diabetes 

Browse other volumes

Article tools

My recent searches

No recent searches.

My recently viewed abstracts